Anti-il36r antibodies

一种抗体、抗原的技术,应用在抗体、抗炎剂、抗受体/细胞表面抗原/细胞表面决定因子免疫球蛋白等方向,能够解决可用治疗有限等问题

Pending Publication Date: 2021-03-16
REGENERON PHARM INC
View PDF16 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] However, currently available treatments for palmoplantar pustulosis (PPP) and palmoplantar pustular psoriasis (PPPP) are limited

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-il36r antibodies
  • Anti-il36r antibodies
  • Anti-il36r antibodies

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0130] Production of Human Antibodies

[0131] Methods for producing human antibodies in transgenic mice are known in the art. In the context of the present invention, any such known methods may be used to prepare human antibodies that specifically bind IL36R (eg IL1RL2). In certain embodiments of the invention, antibodies of the invention are obtained from antibodies immunized with IL36R (e.g., IL1RL2 polypeptides or immunogenic fragments thereof) or with live attenuated or inactivated viruses or with DNA encoding proteins or fragments thereof. mice. Alternatively, IL36R can be produced using standard biochemical techniques, and modified and used as an immunogen. In certain embodiments of the invention, the immunogen may be an IL36R (eg, IL1RL2) polypeptide vaccine. In certain embodiments, one or more booster injections may be administered. In certain embodiments, the immunogen may be a recombinant IL36R polypeptide (eg, IL1RL2) expressed in E. coli or in any other eukary...

example

[0204] The following examples are set forth to provide those of ordinary skill in the art

[0205] A full disclosure and description of how to make and use the methods and compositions of the invention,

[0206] and the examples are not intended to limit

[0207] What the inventors consider to be the scope of their invention.

example 1

[0208] Example 1 : Generation of human antibodies that specifically bind IL-36R

[0209] By immunizing VELOCIMMUNE mice (i.e., mice engineered to contain DNA encoding human immunoglobulin heavy chain and kappa light chain variable regions) with a DNA immunogen containing the full-length IL36R (IL-1RL2) sequence, Obtain anti-IL36R antibody. Antibodies were monitored by IL36R-specific immunoassays, and fully human anti-IL36R antibodies were isolated and purified. The V of the antibody generated as described herein H and V L Two exemplary comparisons between its germline counterparts are set forth in figure 1 and figure 2 middle.

[0210] Table 1. Immunoglobulin chain sequences of the invention*

[0211]

[0212]

[0213]*corresponds to V H , CDR-H1, CDR-H2, CDR-H3, V L , CDR-L1, CDR-L2 and CDR-L3 numbers refer to the SEQ ID NOs set forth herein. "PEP" refers to an amino acid sequence; "DNA" refers to a nucleotide sequence.

[0214] SEQ ID NO:1

[0215] GAAGT...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides antibodies and antigen-binding fragments (e.g., human antibodies) that bind specifically to human IL-36 receptor. Methods for treating or preventing diseases mediated byIL36R (e.g., skin or colon inflammatory conditions such as palmo-plantar pustular psoriasis, palmoplantar pustulosis, generalized pustular psoriasis, ulcerative colitis or IBD) using the antibodies and fragments are also provided along with methods of making the antibodies and fragments.

Description

[0001] Cross References to Related Applications [0002] This application asserts U.S. Provisional Patent Application No. 62 / 698,482, filed July 16, 2018, U.S. Provisional Patent Application No. 62 / 846,989, filed May 13, 2019, and U.S. Provisional Patent Application No. 62 / 846,989, filed June 25, 2019 of the benefit of Application No. 62 / 866,028, each of which is incorporated herein by reference in its entirety. technical field [0003] The field of the invention relates in part to antibodies that bind to the IL-36 receptor and the use of such antibodies to treat inflammatory disorders including psoriasis or inflammatory bowel disease. [0004] SEQUENCE LISTINGS INCORPORATE BY REFERENCE [0005] The Sequence Listing is incorporated herein by reference as an ASCII text document named 36432_10484US01_SequenceListing, 176KB in size, created on July 15, 2019 and filed with the United States Patent and Trademark Office via EFS-Web and Trademark Office). Background technique ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(China)
IPC IPC(8): C07K16/28A61K39/395A61P37/06A61P17/06
CPCC07K16/2866C07K2317/21C07K2317/76C07K2317/92C07K2317/33A61K2039/505A61P37/06C07K2317/34C07K2317/94A61P17/06A61P1/00A61P17/00C07K2317/56C07K2317/565A61K9/0019A61K45/06A61P29/00
InventorJ·法尔赫斯特E·戈尔诺娃W·沃尔森S·哈希纳托
OwnerREGENERON PHARM INC